Introduction
Chronic Obstructive Pulmonary Disease (COPD) is characterized by chronic airflow limitation, as assessed by a reduced post-bronchodilator FEV 1 / FVC ratio <0.7 (where FEV 1 is forced expiratory volume in the first second and FVC is forced vital capacity) 1 . The prevalence of COPD is estimated at 70 per 1000 population 2 . Quadriceps muscle strength and peak aerobic capacity ( V O 2 ) are decreased in patients with COPD compared to healthy age-matched control subjects 3, 4 . Significant reductions in quadriceps muscle strength and peak V O 2 not only reflect a loss in physical fitness, but are also associated with increased dyspnea, fatigue, morbidity, and mortality in patients with COPD [4] [5] [6] [7] . Aging has been associated with a progressive decline in quadriceps muscle strength and peak V O 2 in healthy subjects 8, 9 . Quadriceps muscle strength and peak V O 2 have been demonstrated to decline over time in outpatients with COPD [10] [11] [12] . However, the reductions in quadriceps muscle strength and peak V O 2 in patients with COPD have only been studied in relatively small samples over a period of 1 to 5 years. Moreover, results were not corrected for concurrent decline in lean muscle mass. However, lean muscle mass is expected to decrease over time, in particular in the lower limbs 13 and it is a well-known determinant of quadriceps muscle strength and peak V O 2 in patients with COPD 14, 15 . In addition, gender and gas transfer capacity of the lungs have both been shown to be determinants of lean muscle mass, quadriceps muscle strength, and peak V O 2 in COPD and should therefore also be taken into consideration 10, 14, [16] [17] [18] [19] [20] . We hypothesized that an age-graded reduction in quadriceps muscle strength and peak V O 2 in COPD patients could largely be attributed to concurrent diminishment in lower-limb lean muscle mass (LL-LMM). In order to address this hypothesis, we retrospectively analyzed a large clinical cohort of both women and men with COPD undergoing initial evaluation for pulmonary rehabilitation 21 . We compared quadriceps muscle strength and peak V O 2 in women and men while stratifying for age and gas transfer capacity. Indeed, gas transfer capacity is more closely related to peak V O 2 and quadriceps muscle strength than the degree of airflow limitation in patients with COPD 18, 22 . We then corrected for LL-LMM to see whether and to what extent the age-graded reduction remained evident.
Methods

Study subjects and design
We extracted data from the records of 1963 clinically stable patients with the diagnosis of 'COPD' who were evaluated at the CIRO+, a centre of expertise for chronic organ failure in Horn (the Netherlands) 21 between January 1, 2005 and January 1, 2010. Of these records, 967 met the following inclusion criteria: presence of all necessary data, a post-bronchodilator FEV1/ FVC ratio ≤0.70, the transfer factor for carbon monoxide (D L CO), peak VO 2 , isokinetic quadriceps peak torque, LL-LMM, and no repeat admission for the same patient. All patients with long-term oxygen therapy were excluded from the analyses due to the lack of a determined peak VO 2 . These retrospective analyses are institutional review board-exempt due to the use of de-identified, pre-existing data.
All patients were referred by chest physicians from multiple hospitals in 2 southeastern provinces in the Netherlands for a comprehensive pulmonary rehabilitation program 21 . Patients used short-acting β 2 agonist (33%); short-acting anticholinergic (15%); combination of short-acting β 2 agonist and short-acting anticholinergic in one device (20%); long-acting β 2 agonist (21%); long-acting anticholinergic (69%); inhalation corticosteroids (14%); long-acting β 2 agonist and inhalation steroids in one device (71%); theophylline (14%); 36% N-acetyl cystein (34%); maintenance oral steroids (13%); or a combination thereof.
Methods
As part of a 3-day routine baseline assessment 21 Palavras-chave: doença pulmonar obstrutiva crônica; massa magra dos membros inferiores; pico de consumo de oxigênio; força muscular do quadrí-ceps; pico de torque isocinético do quadríceps; envelhecimento.
to international recommendations 24, 25 . In addition, patients underwent physical examination by a chest physician (including assessment of body weight and height) and medical history as described before 26 . Finally, single-leg isokinetic quadriceps peak torque and LL-LMM were determined using a BIODEX computerized dynamometer and a Lunar Prodigy dual-energy x-ray absorptiometry scan, respectively 13, 15 .
Statistical analyses
All statistical analyses were carried out using GraphPad Prism 4.03 and SPSS 17.0. Data are presented as mean and standard deviation or proportion, as appropriate. Patients were stratified by gender and age (age group 1: ≤50 years; age group 2: 51 to 60 years; age group 3: 61 to 70 years; or age group 4: ≥71 years). Moreover, due to the strong correlation in COPD between peak VO 2 and D L CO 22 and D L CO and quadriceps muscle strength 18 , patients were stratified based on the D L CO: ≤50% predicted and >50% predicted 27 . Please see Table E1 of the online depository for details on the number of patients per stratum (link to online depository: http://www. ciro-horn.nl/wordpress/wp-content/uploads/2011/11/ONLINE-SUPPLEMENT-Age-graded-reductions-in-quadriceps-musclestrength-and-peak-aerobic-capacity-in-COPD.pdf).
A two-tailed unpaired t-test was used to determine differences between women and men and between the D L CO strata. Age-graded differences were assessed using a one-way analysis of variances. Fisher's least significant differences test was used as post-hoc test because of an unequal group size. Stepwise multiple regression analyses were done to assess independent contributors to the variance in isokinetic quadriceps peak torque and peak V . O 2 . A priori, a two-sided level of significance was set at p≤0.05.
Results
Characteristics
COPD severity ranged from mild to very severe. The average resting blood gas values and body mass index were normal. About half of the patients were current smokers ( Table  1) . LL-LMM, isokinetic quadriceps peak torque, and peak VO 2 were clearly reduced compared to published data from healthy elderly subjects 15, 17, 28 . At peak exercise, patients generally had little ventilatory reserve and rather high Borg symptom scores for dyspnea and fatigue (Table 2 ).
Gender differences
On average, the male COPD patients were older, had a worse pulmonary function and a higher score on the Charlson co-morbidity index compared to the female patients. Moreover, men had a significantly higher LL-LMM (mean difference: 4.3 kg, p<0.01), isokinetic quadriceps peak torque (mean difference: 29.5 Newton-meter, p<0.01), and absolute peak VO 2 (mean difference: 211 ml/min, p<0.01), while the women had a significantly higher peak VO 2 after adjustment for LL-LMM (mean difference: 9.8 ml/min/kg LL-LMM, p<0.01). Non-significant gender-related differences were found for peak ventilation (% maximal voluntary ventilation), peak heart rate (% calculated maximum heart rate), Borg symptom scores, and isokinetic quadriceps peak torque after adjustment for LL-LMM (Table 2) .
Gender-related differences after stratification for age As expected, men had a significantly higher mean LL-LMM, isokinetic quadriceps peak torque, and absolute peak V O 2 compared to women also after stratification for age (Figures 1a to 1c) . Moreover, men of age ≥51 years had a significantly higher mean isokinetic quadriceps peak torque after adjustment for LL-LMM compared to women (Figure 1d ). In contrast, gender-related differences in absolute peak V O 2 disappeared after adjustment for LL-LMM. Indeed, mean peak VO 2 adjusted for LL-LMM was significantly higher in women of age ≥51 years compared to male peers (Figure 1e ). See Table E2 of the online depository for more details on mean differences between groups and p-values.
Age-related difference after stratification for gender
Generally, patients of age ≤50 years had a higher isokinetic quadriceps peak torque and peak VO 2 (absolute values and after adjustment for LL-LMM) compared to older patients, irrespective of gender (Figure 1 ). Male patients with age ≥71 years had the lowest LL-LMM compared to younger male patients. No age-graded reductions were found in LL-LMM in female patients (Figure 1a) . See Table E3 of the online depository for more details on mean differences between groups and p-values.
D L CO-related differences after stratification for gender and age
After stratification for age, women with a D L CO >50% predicted had a higher mean LL-LMM (in women 51 to 70 years of age; Figure 2a ), isokinetic quadriceps peak torque (in women of age ≤50 years; Figure 2b ) and absolute peak VO 2 ( Figure 2c ) compared to women with a D L CO ≤50% predicted. Moreover, peak VO 2 remained different between both subsets after adjustment for LL-LMM (Figure 3b ). Isokinetic quadriceps peak torque adjusted for LL-LMM was not different between D L CO strata (Figure 3a) . See Table E4 of the online depository for more details on mean differences between groups and p-values.
A similar pattern was observed in the male patients after stratification for age and D L CO. Indeed, male patients with a D L CO >50% predicted had a higher mean LL-LMM (in men of age ≥51 years; Figure 2d ), isokinetic peak torque (in men ≤70 years of age; Figure 2e ) and absolute peak VO 2 ( Figure 2f ) compared to male patients with a D L CO ≤50% predicted. Th ese D L CO-related diff erences remained after adjustment for LL-LMM, in particular for peak VO 2 (Figures 3c and 3d ). See Table  E5 of the online depository for more details on mean diff erences between groups and p-values.
Age-related differences after stratification for gender and D L CO
Women with a D L CO ≤50% predicted showed an agegraded reduction in isokinetic quadriceps peak torque ( Figure 2b ) and peak V O 2 (Figure 2c ). These age-graded reductions remained after adjustment for LL-LMM (Figures 3a  and 3b) . The age-graded reductions in isokinetic quadriceps peak torque ( Figure 2b ) and peak V O 2 ( Figure 2c ) were even more explicit in the women with a D L CO >50% predicted. LL-LMM did not show an age-graded reduction in either D L CO group (Figure 2a) . A similar pattern was observed for the male patients after stratification for D L CO (Figures 2d,  2e, 2f, 3c, and 3d) . See Table E6 of the online depository for more details on mean differences between groups and p-values.
Stepwise multiple regression model
A stepwise multiple regression analysis ascertained LL-LLM, age, peak VO 2 , and gender to be significant determinants of isokinetic quadriceps peak torque. This model explained 56.4% of the variance in isokinetic quadriceps peak torque (p=0.01). D L CO (p=0.73), FEV 1 (p=0.16), and BMI (p=0.07) did not contribute to the model. Lower-limb lean muscle mass, isokinetic quadriceps peak torque, and peak aerobic capacity after stratification for age in 374 women and 593 men with COPD. Table E2 in the online supplement for more details. Lower-limb lean muscle mass, isokinetic quadriceps peak torque, and peak aerobic capacity after adjustment for age and D L CO in women and men with COPD.
A stepwise multiple regression analysis ascertained isokinetic quadriceps peak torque, D L CO, FEV 1 , BMI, age and LL-LMM to be signifi cant determinants of peak V O 2 . Th is model explained 59.3% of the variance in peak V O 2 (p=0.01). Gender did not contribute to the model (p=0.22).
Discussion
As we expected, quadriceps muscle strength and peak V O 2 were related to age in patients with COPD, particularly in those with D L CO >50% predicted. Yet, counter to our hypothesis LL-LMM did not account for the relationship of age with quadriceps muscle strength and peak V O 2 . Indeed, an age-graded reduction in LL-LMM was only present in the older men with a D L CO >50% predicted. Th e results of this study suggest the presence of age-related qualitative abnormalities in lower-limb muscles in patients with COPD (i.e. a decrease in isokinetic peak torque per unit weight of lower-limb lean muscle mass and/or a decrease in peak V O 2 per unit weight of lower-limb lean muscle mass).
An age-related decline in quadriceps muscle strength and peak V O 2 is well established in healthy subjects and in cardiac patients 8, 9, 29 . Moreover, small but signifi cant reductions in quadriceps muscle strength 10 and peak V O 2 11,12 were found in (mostly male) COPD patients over a 1 to 5 year period, respectively. To the best of our knowledge, this is the fi rst study to show an agegraded reduction in quadriceps muscle strength and peak V O 2 in patients with COPD after correction for possible confounding factors, such as gender, LL-LMM, and D L CO. More importantly this study corroborates the previously identifi ed decrease in lower-limb muscle function in patients with COPD 3, 16 . Moreover, our results also highlight age-graded diff erences between men and women, which also parallels previous fi ndings 30 . Lower-limb muscle weakness can occur without an overt loss of LL-LMM in patients with COPD suggesting the presence of qualitative skeletal muscle abnormalities 16 , particularly in women 3 . Th e present fi ndings are in line: skeletal muscle function can decrease without a decrease in LL-LMM in patients with COPD, in particular in women (Table E2 ). In healthy elderly subjects, gender diff erences exist in the contractile properties of lower-limb muscles. Indeed, type I and IIA fi bers from older healthy men were generally stronger than similar fi bers from older women even after adjusting for size 31 .
Whether and to what extent gender diff erences in muscle contractile properties are also present in COPD remains currently unknown 32 .
There are several factors that may explain the overt loss in peak V O 2 (absolute and corrected for LL-LMM) in COPD. Patients with COPD have a significantly lower mitochondrial density 33 and activity 34 , as well as a lower oxidative enzyme activity 35 and a lower mechanical efficiency 36 . There are also fewer capillaries per muscle fiber in patients with COPD. Lastly, there are more type II muscle fibers in patients with COPD compared to healthy age-matched control subjects 37 . A worsening of the above-mentioned intramuscular manifestations over time may explain the age-related differences in peak V O 2 . However, most of these intramuscular changes have been identified in small crosssectional studies of mostly men, focusing mainly on the vastus lateralis muscle and GOLD stages 3 and 4. Coupled with our results, these mechanistic insights underline the importance of continued research on this phenomenon of loss of lower-limb muscle V O 2 . Indeed, there is great potential for identifying new therapeutic targets 38 . Signifi cant diff erences in lower-limb muscle function were found in female (Figures 3a and 3b) and male COPD patients ( Figures 3c and 3d) after stratification for D L CO. This seems to be in line with previous findings of Amann et al. 39 , who reported that the high susceptibility to lower-limb muscle fatigue in patients with COPD is in part attributable to insufficient oxygen transport as a consequence of exaggerated arterial hypoxemia and/or excessive respiratory muscle work. Moreover, quadriceps muscle strength was positively related to D L CO in patients with COPD 18 . Age-related reductions in LL-LMM have been reported in healthy women and men 17 . Hopkinson at al. 10 reported a non-significant decline of 0.2 kilogram in fat-free mass during a 1-year follow-up period in 64 COPD patients 10 . Also in the current cross-sectional analyses no age-graded reductions in LL-LMM were found, except for the older male COPD patients with a D L CO >50% predicted (Figure 3d and Table E6 of the online supplement). It remains difficult to understand the lack of age-graded reductions in LL-LMM in patients with COPD.
The external validity of the present findings is limited to COPD patients without long-term oxygen therapy. Thus the present data should not be uncritically applied to GOLD IV patients with long-term oxygen therapy. Obviously, a major limitation of the present analysis is the lack of a healthy control group and the lack of information about daily physical activity levels. However, quadriceps muscle strength and peak V O 2 have been found to decline over time in healthy subjects 9, 30 . Moreover, the influence of daily physical inactivity on an age-related decline in peak V O 2 remains a matter of debate 8, 30 . Patients with COPD have a reduced level of daily physical activity, which is present even in the earliest stages of the disease 40 . It is for this reason that it is not very surprising that quadriceps muscle strength and peak V O 2 in patients with COPD is very low compared to healthy subjects 8, 17, 30 and not unlike that in patients entering cardiac rehabilitation 29 . Accordingly, the majority of subjects with COPD in our study (98.8%) had a metabolic equivalent below 8, which is an identified risk factor of death from any cause 6 . In addition, an age-related decline in peak V O 2 can explain, at least in part, the development of disability in patients with COPD 41 . Indeed, GOLD stage II patients use a higher proportion of their (reduced) peak V O 2 compared to healthy elderly subjects during the performance of simple, self-paced domestic activities of daily living 4 . Finally, large longitudinal studies are needed to corroborate the current findings.
In summary, we have found that lower-limb muscle quality is lower in older patients with COPD, also after stratification for gender and gas transfer. Therefore, prevention of an age-graded decline in quadriceps muscle strength and peak V O 2 may need to become an outcome of the management of patients with COPD.
